The Stocks Driving Lorne Steinberg’s December 2024 Strategy

The financial world is buzzing as Lorne Steinberg, president of Lorne Steinberg Wealth Management, shares his latest insights and market outlook. With a focus on global value stocks and fixed income, Steinberg provides clarity amidst a shifting economic landscape, offering investors a blend of optimism and caution. His top picks—Allstate, CVS, and Nestlé—reflect his strategic approach to identifying undervalued opportunities with significant potential for growth.

Market Outlook: Riding the Waves of Change

The recent U.S. election has ushered in a wave of investor optimism. A stock market rally is underway, fueled by prospects of reduced government regulation and anticipated tax cuts. Adding to the optimism, the U.S. Federal Reserve is expected to implement further interest rate reductions, a move that could stimulate economic activity and sustain investor confidence. The U.S. economy remains resilient, standing out as a beacon of strength in contrast to the more subdued growth in Europe, Canada, and other regions.

China’s economic slowdown remains a critical factor, dampening earnings growth for many multinational corporations. However, the Chinese government’s ongoing stimulus efforts are expected to stabilize the economy within the coming year. This stabilization could serve as a counterbalance to global economic uncertainties, offering a more harmonious growth trajectory.

The robust performance of U.S. corporate earnings, combined with strategic policy shifts, has also bolstered the U.S. dollar. This currency strength creates an attractive opportunity for investors to acquire foreign assets at more favorable prices. European, U.K., and Japanese markets, long overlooked, present compelling valuations compared to the more expensive U.S. markets.

Allstate: A Pillar of Value and Stability

Allstate Corporation stands as a testament to disciplined management and exceptional value creation. As a leading property and casualty insurer, Allstate has demonstrated a remarkable ability to generate free cash flow consistently. Over the past 15 years, the company has repurchased more than half of its outstanding shares while simultaneously expanding its market share and increasing dividends.

The insurance sector has experienced significant premium hikes in recent years, and Allstate is poised to capitalize on this trend. Its earnings are projected to grow by over 10% annually, underpinned by strong operational efficiency and market positioning. Trading at a price-to-earnings (P/E) ratio of 11 and offering a 1.8% dividend yield, Allstate represents a compelling investment with a solid margin of safety. For investors seeking a blend of stability and growth, Allstate delivers on all fronts.

CVS: Reinventing Healthcare Delivery

CVS Health Corporation emerges as a transformative force in the U.S. healthcare landscape. Positioned at the forefront of value-based care, CVS is leveraging its extensive medical, pharmacy, and laboratory data to revolutionize healthcare delivery. By offering cost-effective and efficient solutions, CVS is setting new benchmarks in the industry.

The company’s pharmacies are well-equipped to provide services such as COVID-19 vaccine administration, adding a layer of convenience and accessibility for patients. Although recent earnings have faced headwinds from integration challenges and a soft retail environment, these obstacles are being systematically addressed.

With a P/E ratio of 10 and a dividend yield of 4.8%, CVS presents an attractive opportunity for investors. The company’s focus on innovation and operational improvements positions it for substantial earnings growth in the near future, making it a strategic pick in a rapidly evolving industry.

Nestlé: A Global Powerhouse at a Turning Point

Nestlé S.A. continues to reign as the world’s largest food and beverage company, commanding a diverse portfolio that spans coffee, pet care, nutrition, and dairy products. Its top categories—coffee, pet care, and nutrition—account for a significant portion of its revenue, reflecting the company’s ability to cater to evolving consumer preferences. Moreover, Nestlé holds a 20% stake in L’Oréal, which represents a substantial portion of its market capitalization.

Despite its impressive legacy, Nestlé has faced challenges in recent years, with revenue growth stagnating. The appointment of a new CEO marks a pivotal moment for the company, signaling a renewed focus on streamlining operations and divesting underperforming assets. Revenue growth is projected to regain momentum by 2025, and the company’s shares, currently trading near a 10-year low, offer an attractive entry point for investors. With a 4% dividend yield, Nestlé combines the appeal of stability with the promise of long-term growth.

Conclusion: A Strategic Vision for Global Investing

Lorne Steinberg’s top picks exemplify a disciplined approach to navigating today’s complex financial environment. Allstate’s operational excellence, CVS’s transformative role in healthcare, and Nestlé’s resilience and reinvention demonstrate the power of identifying value in diverse sectors. As global markets continue to evolve, Steinberg’s insights provide investors with a roadmap to capitalize on opportunities while mitigating risks. The blend of optimism and strategic foresight underscores the importance of staying agile and informed in an ever-changing investment landscape.